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Abstract
We investigated the effects of pentoxifylline (PTX) on endotoxin-induced diaphragmatic dys-
function in vitro. Seventy-two rats were divided into 3 groups: a group in which endotoxin (20
mg/kg) was injected intraperitoneally (endotoxin-group), a group in which PTX (100 mg/kg) was
injected intraperitoneally 30 min before injection of endotoxin (endotoxin-PTX group), and a
group in which only saline was given (sham group). Left hemidiaphragms were removed 4 h after
injection of endotoxin. We evaluated the diaphragmatic contractility by twitch characteristics and
force-frequency curves in vitro. We measured serum TNF-alpha concentrations, diaphragm mal-
ondialdehyde (MDA) levels (an index of oxygen-derived free radical-mediated lipid peroxidation),
and diaphragm cAMP concentrations. Diaphragmatic force generation capacity was signifi cantly
reduced after injection of endotoxin. Serum TNF-alpha concentrations and diaphragmatic MDA
levels were significantly elevated after injection of endotoxin. PTX administration significantly
improved diaphragmatic contractility and prevented the elevation in TNF-alpha concentrations
and MDA levels after injection of endotoxin. There were no significant changes in the diaphragm
cAMP concentrations among the 3 groups. These results demonstrated that PTX administra-
tion prevented endotoxin-induced diaphragmatic dysfunction without changing diaphragm muscle
cAMP concentrations. The protective effects of PTX against endotoxininduced diaphragmatic
contractile deterioration might be caused by attenuating TNF-alpha-mediated oxygen-derived free
radical production.
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iaphragmatic dysfunction may contribute to the 
development of respiratory failure during sep-
sis [1ﾝ3].  Diaphragm muscle impairment and/or dia-
phragm muscle fatigue are thought to be the cause of 
diaphragmatic dysfunction occurring during sepsis 
[1].
　 Recent evidence suggests that tumor necrosis fac-
tor-alpha (TNF-ｸ) plays an important role in the 
development of diaphragmatic dysfunction during sep-
sis.  Intravenous administration of TNF-ｸ resulted in 
impairment of diaphragmatic contractility in dogs [4].  
Expression of TNF-ｸ mRNA was observed in dia-
phragm muscle cells after injection of endotoxin.  
Preinjection of TNF-ｸ antibody prevented the dete-
rioration of diaphragmatic contractility after injection 
of endotoxin [5].  TNF-ｸ is known as a potent activa-
tor of polymorphonuclear leukocytes (PMN),  which 
trigger the production of oxygen-derived free radicals 
D
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[6].  Oxygen-derived free radicals are thought to be 
responsible for the development of diaphragmatic dys-
function elicited by TNF-ｸ [3,  7].
　 Pentoxifylline (PTX) is a methylxanthine deriva-
tive and nonspeciﬁ c phosphodiesterase inhibitor that 
has been used in the treatment of peripheral arterial 
disorders [8].  There are several lines of evidence 
that PTX has beneﬁ cial eﬀ ects against sepsis [9ﾝ13].  
PTX improves survival in animal models of endotoxic 
shock [14,  15].  It has been suggested that the bene-
ﬁ cial eﬀ ects of PTX against sepsis are due to inhibi-
tion of synthesis and bioactivity of TNF-ｸ [14ﾝ17].  
However,  the eﬀ ect of PTX against diaphragmatic 
contractility during sepsis remains unknown.  
Therefore,  we hypothesized that PTX has a preven-
tive eﬀ ect on diaphragmatic dysfunction after injection 
of endotoxin by inhibiting the synthesis and bioactivity 
of TNF-ｸ and that this eﬀ ect is mediated by the 
inhibitory eﬀ ects of oxygen-derived free radical pro-
duction.
　 Thus,  the present study was designed to evaluate 
the eﬀ ects of PTX on diaphragmatic contractility 
after injection of endotoxin.  We also measured the 
TNF-ｸ concentration in serum and the diaphragm 
malondialdehyde (MDA) level,  as an index of oxygen-
derived free radical-mediated lipid peroxidation,  after 
injection of endotoxin.  Since PTX has multiple ben-
eﬁ cial eﬀ ects on the inﬂ ammatory cascade by increas-
ing intracellular cyclic adenosine monophosphate 
(cAMP),  we also measured diaphragm muscle cAMP 
concentrations.
Materials and Methods
　 This study was approved by the Committee on 
Animal Research of our institution.  The care and 
handling of animals were in accord with National 
Institutes of Health guidelines.
　 Animals and protocol for induction of sepsis.
Experiments were conducted on seventy-two 8- to 
10-week-old male Wistar rats (weighing 250ﾝ300 g).  
Rats were randomly divided into 3 groups:
a) sham group (n＝24),  in which a sterile saline (2 ml) 
was administered intraperitoneally twice at 30 min 
intervals; b) endotoxin group (n＝24),  in which a 
sterile saline (2 ml) was administered intraperitone-
ally 30 min before the intraperitoneal injection of 
endotoxin (lipopolysaccharides from Escherichia 
coli; 055: B5 Sigma Chemical Co.,  St.  Louis,  MO,  
USA; 20 mg/kg) suspended in 2 ml saline; and c) 
endotoxin-PTX group (n＝24),  in which PTX (Sigma 
Chemical Co.; 100 mg/kg) suspended in 2 ml saline 
was administered intraperitoneally 30 min before the 
intraperitoneal injection of endotoxin.
　 The left hemidiaphragm was removed 4 h after the 
injection of endotoxin or saline.  Blood samples were 
taken 90 min after the injection of endotoxin or saline.
　 In vitro diaphragm muscle strip. The left 
hemidiaphragms were rapidly removed from the rats 
(n＝18) killed with deep O2-isoﬂ urane anesthesia and 
bleeding.  Strips approximately 10 mm in width,  not 
containing the phrenic nerves,  were dissected from the 
medial aspect of the left hemidiaphragm of each rat.  
All strips were removed together with the associated 
ribs and central tendon.  The isolated strips were 
placed in an organ bath containing oxygenated Krebs 
solution (27 °C).  The strips were mounted vertically 
in a tissue chamber,  with the central tendon superi-
orly positioned and attached to a Grass FT-10 force 
transducer (Grass Instruments,  Quincy,  MA,  USA),  
which was connected to a micropositioner,  and posi-
tioned between 2 platinum plates.  The strips were 
stimulated with supramaximal currents (1.2 to 1.3 
times the current required to elicit maximal tension) 
delivered via platinum ﬁ eld electrodes.  The current 
was supplied by an ampliﬁ er driven by a Grass S48 
stimulator.  In these experiments,  d-tubocurarine 
(Sigma Chemical Co.) at a concentration of 15 mM was 
added to the Krebs solution to eliminate the activation 
of intramuscular nerve branches.
　 Stimulation paradigm. The strips were 
allowed to equilibrate in the organ bath for 20 min.  
The optimal force-length (L0) relationship was then 
determined by adjusting the micropositioner between 
intermittent stimulations of the muscle strips.  All 
stimulations during the study were performed at L0.  
Muscle contractile characteristics were then assessed 
according to twitch characteristics and the force-fre-
quency relationship.
　 Twitch characteristics. Peak twitch tension,  
contraction time (time to peak tension),  and half-
relaxation time (time required for tension to decay 
from maximum to half-maximum) were calculated from 
single twitches (0.1 Hz stimulation) that were recorded 
at a high speed (100 mm/s).
　 Force-frequency relationship. Force-
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frequency relationships were determined by stimulat-
ing the diaphragm strips tetanically at frequencies 
from 10 to 100 Hz over 10-Hz increments.  An inter-
val of 10 s was used between stimuli,  and the pulses 
were 0.2 ms in duration with a train duration of 400 
ms.  Force-frequency relationships were determined 
20 min after determination of L0.
　 Measurement of TNF-ｸ concentration.
Blood samples (n＝18) were centrifuged,  and the 
plasma was frozen in liquid nitrogen.  Plasma TNF-ｸ 
concentrations were assayed with an enzyme-linked 
immunoabsorbent assay (Biosource,  Camarillo CA,  
USA).  According to the manufacturer,  the sensitivity 
is 2.3 pg/ml.
　 Measurement of malondialdehyde levels.
The MDA level was determined from the reaction of 
N-methyl-2-phenylindole with MDA using Bioxytech 
LPO-586 (Oxis International,  Foster City,  OR,  
USA).  Brieﬂ y,  diaphragm muscle samples (n＝18) 
were homogenized with 20 mM Tris buﬀ er,  pH 7.4,  
containing 5 mM butylated hydroxytoluene,  to make a 
20ｵ homogenate.  The homogenate was centrifuged 
at 3,000×g and for 10 min at 4 °C.  Then,  650 ｻL of 
the R1 reagent,  N-methyl-2-phenylindole in 25ｵ 
methanol/75ｵ acetonitrile,  and 150 ｻL concen-
trated 12 N HCl were added to 200 ｻL of the super-
natant and incubated at 45 °C for 60 min.  Turbid 
samples were centrifuged at 15,000×g for 10 min.  
Measurement of 586 nm absorbance was performed.  
Final MDA levels were expressed as nmol MDA per 
mg protein.  Protein concentrations were measured by 
the Lowry method [18,  19].
　 Measurement of cAMP concentrations. The 
diaphragmatic strips (n＝18) were homogenized in 10 
volumes of Hank’s balanced salt solution (without cal-
cium and magnesium) containing 5 mM EDTA with a 
homogenizer.  The homogenates were centrifuged at 
1,000×g for 10 min at 4 °C.  The extraction of cAMP 
from the supernatant was carried out by the solid-
phase extraction method using Amprep SAX columns 
(Amersham,  Buckinghamshire,  UK).  The concentra-
tions of cAMP were measured by the Biotrak cAMP 
enzyme immunoassay system (Amersham).  The result-
ing pellets were solubilized and used to measure pro-
tein concentrations by the Lowry method [18,  20].
Study design.
 Experiment 1.  Eﬀ ect of pentoxifylline on dia-
phragmatic contractility.
　 Eighteen rats were used to measure diaphragmatic 
contractility after the injection of endotoxin.
 Experiment 2.  Eﬀ ect of pentoxifylline on plasma 
TNF-ｸ concentrations.
　 Eighteen rats were used to measure plasma TNF-
ｸ concentrations after the injection of endotoxin.
 Experiment 3.  Eﬀ ect of pentoxifylline on dia-
phragmatic MDA levels.
　 Eighteen rats were used to measure diaphragmatic 
MDA levels after the injection of endotoxin.
 Experiment 4.  Eﬀ ect of pentoxifylline on dia-
phragmatic cAMP concentrations.
　 Eighteen rats were used to measure diaphragmatic 
cAMP concentrations after the injection of endotoxin.
　 In these experiments,  6 animals each from the 
sham group,  the endotoxin group and the endotoxin-
PTX group were tested.
　 Data analysis. The cross-sectional area was 
calculated by dividing the muscle mass by the length in 
cm,  and the density of muscle was assumed to be 
1.056 g/cm3.  Tension was calculated as force per unit 
of cross-sectional area (kg/cm2).  Statistics were cal-
culated using a software program (Macintosh 
StatView J 4.02; Abacus Concepts,  Berkeley,  CA,  
USA).  Comparisons of force-frequency curves among 
the groups were made by repeated-measures analysis 
of variance (ANOVA).  Comparisons of the diaphragm 
muscle twitch characteristics,  peak tetanic tension,  
TNF-ｸ concentration,  MDA levels and cAMP con-
centration among the groups were made with one-way 
analysis of variance (ANOVA) combined with Scheﬀ e’s 
procedure used for post hoc comparison of data sets.  
Diﬀ erences with a p value less than 0.05 were consid-
ered signiﬁ cant.  Data are presented as means±
SEMs.
Results
　 Twitch characteristics. The twitch character-
istics of the sham group,  endotoxin group and endo-
toxin-PTX group are shown in Table 1.  Peak twitch 
tension in the endotoxin group was signiﬁ cantly lower 
than that in the sham group (p＜0.01).  Peak twitch 
tension in the endotoxin-PTX group was signiﬁ cantly 
higher than that in the endotoxin group (p＜0.01).
103Eﬀ ect of Pentoxifylline on Diaphragmatic ContractilityApril 2008
3
Danjo et al.: Effect of pentoxifylline on diaphragmatic contractility in septic
Produced by The Berkeley Electronic Press, 2008
　 There were no signiﬁ cant diﬀ erences in half RT 
and CT among the 3 groups.
　 Diaphragm force-frequency relationship.
The force-frequency curves of the sham group,  endo-
toxin group and endotoxin-PTX group are shown in 
Fig.  1.  The force-frequency curve of the endotoxin 
group was signiﬁ cantly lower than that of the sham 
group (p＜0.01),  and the force-frequency curve of the 
endotoxin-PTX group was signiﬁ cantly higher than 
that of the endotoxin group (p＜0.01).
　 Peak tetanic tensions were 2.23±0.07 kg/cm2 in 
the sham group,  1.53±0.08 kg/cm2 in the endotoxin 
group,  and 2.18±0.11 kg/cm2 in the endotoxin-PTX 
group.  Peak tetanic tension in the endotoxin group was 
signiﬁ cantly lower than that in the sham group (p＜
0.01),  and peak tetanic tension in the endotoxin-PTX 
group was signiﬁ cantly higher than that in the endo-
toxin group (p＜0.01).
　 TNF-ｸ concentrations. Blood TNF-ｸ con-
centrations are shown in Table 2.  Blood TNF-ｸ con-
centrations increased after endotoxin administration.  
Blood TNF-ｸ concentration in the endotoxin-PTX 
groups was signiﬁ cantly lower than that in the endo-
toxin group (p＜0.01).
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Table 1　 Eﬀ ect of pentoxifylline on diaphragmatic contractility
Group TT (kg/cm2) CT (ms) 1/2RT (ms)
sham 0.45±0.02 44.4±0.85 30.3±0.89
endotoxin 0.33±0.02＊＊ 46.5±0.76 35.0±1.29
endotoxin-PTX 0.41±0.02＃＃ 46.9±0.60 32.9±1.97
CT､  contraction time; TT､  twitch tension; 1/2RT､  half relaxation 
time.  Values are means±SEM.  ＊＊p＜0.01 vs sham group.  ＃＃p
＜0.01 vs endotoxin group.
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Fig. 1　 Diaphragmatic force-frequency curves in 3 experimental 
groups.
Values are means±SEM.  The force-frequency curve of the 
endotoxin group was signiﬁ cantly lower than that of the sham group 
(p＜0.01).  The force-frequency curve of the endotoxin-PTX group 
was signiﬁ cantly higher than that of the endotoxin group (p＜0.01).
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Fig. 2　 Diaphragmatic malondialdehyde levels in three 
experimental groups.
Values are means±SEM.  ＊＊p＜0.01 vs sham group.  ＃＃p＜0.01 
vs endotoxin group.  The malondialdehyde level of the endotoxin 
group was signiﬁ cantly higher than that of the sham group (p＜
0.01).  The malondialdehyde level of the endotoxin-PTX group was 
signiﬁ cantly lower than that of endotoxin group (p＜0.01).
Table 2　 Eﬀ ect of pentoxifylline on plasma TNF-ｸ concent-
rations
Group TNF-ｸ (ng/ml)
Sham NOT DETECTABLE
Endotoxin 23.1±5.12
endotoxin-PTX 0.24±0.03＊＊
Values are means±SEM. ＊＊p＜0.01 vs endotoxin group.
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　 MDA levels. Diaphragmatic MDA levels are 
shown in Fig.  2.  The diaphragmatic MDA level in the 
endotoxin group was signiﬁ cantly higher than that in 
the sham group (p＜0.01).  The diaphragmatic MDA 
level in the endotoxin-PTX group was signiﬁ cantly 
lower than that in the endotoxin group (p＜0.01).
　 cAMP levels. The cAMP concentrations are 
shown in Fig.  3.  There were no signiﬁ cant diﬀ er-
ences in cAMP concentrations among the 3 groups.
Discussion
　 The present study demonstrated that diaphrag-
matic contractility was impaired after endotoxin 
administration,  as manifested by reductions in twitch 
tension and a downward shift of force-frequency 
curves.  Serum TNF-ｸ and diaphragmatic MDA levels 
were elevated after endotoxin administration.  PTX 
administration improved endotoxin-induced impairment 
of diaphragmatic contractility.  PTX administration 
prevented the elevation in serum TNF-ｸ and diaphrag-
matic MDA levels.  These results indicated that PTX 
administration improved endotoxin-induced diaphrag-
matic dysfunction by attenuating TNF-ｸ-mediated 
oxygen-derived free radical production.
　 Endotoxin,  TNF-ｸ and free radical produc-
tion. Endotoxin activates macrophages,  which 
produce cytokines such as interleukin-1 (IL-1) and 
TNF-ｸ [21].  TNF-ｸ is thought to be a central medi-
ator of inﬂ ammatory response during endotoxemia and 
has been proposed to mediate sepsis-associated respi-
ratory muscle dysfunction.  TNF-ｸ infusion in dogs 
caused deterioration of diaphragmatic contractility,  
similar to the eﬀ ect of endotoxin injection [4].  TNF-
ｸ gene expression and production occurred in dia-
phragm muscle cells after injection of endotoxin,  and 
pretreatment with TNF-ｸ antibody prevented deterio-
ration of diaphragmatic contractility [5].  However,  
TNF-ｸ itself did not aﬀ ect in vitro isolated diaphragm 
muscle contractility [22].  TNF-ｸ is a potent primer 
of the oxidative activity of PMN [6].  TNF-ｸ is 
thought to be responsible for the diaphragm muscle 
dysfunction by inducing oxygen radicals,  such as 
superoxide,  hydrogen peroxide and hydroxyl radicals 
[3,  5,  7,  19,  23,  24].  Several studies have demon-
strated that free radical scavengers prevent the devel-
opment of respiratory muscle dysfunction [19,  24ﾝ
27].  Therefore,  the oxygen-derived free radicals 
generated in this manner are thought to play an impor-
tant role in endotoxin-induced diaphragm muscle dys-
function.
　 In this study,  endotoxin administration caused 
reductions in diaphragmatic force generation at all 
frequencies.  Diaphragmatic force generation was 
reduced without any changes in contraction time and 
half relaxation time.  This pattern of dysfunction is 
thought to be consistent with either dysfunction of 
contractile proteins or altered sarcolemmal function 
[28,  29].  The elevation in MDA levels indicates that 
oxygen-derived free radicals promote the peroxidation 
of diaphragm lipids [6,  7].  These results suggested 
that oxygen-derived free radicals directly damage dia-
phragm muscle cells,  resulting in a reduction in dia-
phragmatic contractility after endotoxin administra-
tion [3,  7].
　 Eﬀ ects of PTX on TNF-ｸ levels and free 
radical production. In animal models of sepsis,  
the administration of PTX reduces serum TNF-ｸ lev-
els and the lethality of endotoxemia in mice [30].  
PTX has multiple beneﬁ cial eﬀ ects on the inﬂ amma-
tory cascade by modulating the inﬂ ammatory response 
[16].  PTX downregulates the production of various 
pro- and anti-inﬂ ammatory cytokines,  especially by 
increasing intracellular cAMP and decreasing TNF-ｸ 
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Fig. 3　 Diaphragmatic cyclic adenosine monophosphate 
concentrations in three experimental groups.
Values are means±SEM.  There were no signiﬁ cant diﬀ erences in 
cAMP concentrations among the 3 groups.
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synthesis [16].  TNF-ｸ is a potent primer of the oxi-
dative activity of PMN [6].  PTX has been shown to 
inhibit the stimulated oxidative activity of PMN.  PTX 
prevented endotoxin-induced degranulation of PMN 
[17].  In our study,  it was suggested that PTX 
administration prevented endotoxin-induced oxygen-
derived free radical production by reducing TNF-ｸ 
production.
　 Eﬀ ects of PTX on diaphragmatic dysfunc-
tion. This study demonstrated that PTX adminis-
tration improved endotoxin-induced diaphragmatic 
dysfunction by attenuating oxygen-derived free radical 
production.
　 PTX improved muscle force generation mainly at 
high frequencies of stimulation.  PTX did not improve 
muscle-force generation at low frequencies.  PTX 
reduced diaphragmatic MDA levels after endotoxin 
administration,  but the levels were still higher than 
the control levels.  These results suggested that endo-
toxin-induced diaphragmatic contractile dysfunction 
remained after PTX administration.
　 There are several sources of oxygen-derived free 
radicals that might aﬀ ect diaphragmatic contractility 
during sepsis [3,  7,  19,  24,  26].  Free radical for-
mation during contraction is markedly enhanced in 
endotoxin-induced septic animals [3,  7].  Free radi-
cals generated in this manner might account for the 
increased MDA levels after PTX administration.
　 PTX is known to inhibit phosphodiesterase,  
thereby increasing cAMP levels.  Elevated intracel-
lular levels of cAMP are observed following incuba-
tion of human cells,  including PMNs [31],  mono-
cytes [31] and endothelial cells [32] with PTX.  In 
this study,  there were no signiﬁ cant changes in dia-
phragm muscle intracellular cAMP levels.
　 It is well known that ｹ2-adrenoceptor agonists 
improve septic diaphragmatic contractility in vitro by 
increasing diaphragm muscle intracellular cAMP lev-
els [19,  33,  34].  Our study demonstrated that PTX 
improves endotoxin-induced diaphragmatic dysfunction 
by attenuating TNF-ｸ-mediated oxygen-derived free 
radical production rather than by increasing dia-
phragm muscle intracellular cAMP levels.
　 It has been demonstrated that the elimination half-
lives of PTX after intraperitoneal administration in 
rats and mice are almost within 15 min [35,  36].  
Therefore PTX could not increase diaphragm muscle 
cAMP levels 4 h after endotoxin administration.
　 In conclusion,  this study demonstrated that PTX 
administration prevented endotoxin-induced diaphrag-
matic dysfunction.  PTX attenuated diaphragmatic 
dysfunction without changing diaphragm muscle cAMP 
concentrations.  The protective eﬀ ects of PTX against 
endotoxin-induced diaphragmatic contractile deterio-
ration might be due to attenuation of TNF-ｸ-mediated 
oxygen-derived free radical production.
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